The OPKO Renal Division in Miami, FL is dedicated to improving people's lives by treating and preventing the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism through the development of vitamin D therapeutics.
With a focus on promoting health, the division has a strong pipeline of product candidates and has recently presented new clinical data on their flagship product, RAYALDEE ER Calcifediol, at Kidney Week 2023.
Generated from the website